|
1
|
Danzaki K, Matsui Y and Ikawa T:
‘Molecular mechanisms of T cell development and differentiation.’.
Front Immunol. 10(3184)2019.
|
|
2
|
Wilson D, Burn J, Scambler P and Goodship
J: DiGeorge syndrome: Part of CATCH 22. J Med Genet. 30:852–856.
1993.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bosma GC, Custer RP and Bosma MJ: A severe
combined immunodeficiency mutation in the mouse. Nature.
301:527–530. 1983.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Mombaerts P, Iacomini J, Johnson RS,
Herrup K, Tonegawa S and Papaioannou VE: RAG-1-deficient mice have
no mature B and T lymphocytes. Cell. 68:869–877. 1992.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ding Y, Li X and Zhang Y: Thymic stromal
interactions in T cell development and immunity: Insights from
animal models. Immunol Rev. 310:45–56. 2023.
|
|
6
|
Takahama Y: Journey through the thymus:
Stromal guides for T cell development and selection. Nat Rev
Immunol. 6:127–135. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Hadden JW: Thymic endocrinology. Int J
Immunopharmacol. 14:345–352. 1992.PubMed/NCBI View Article : Google Scholar
|
|
8
|
McVay LD, Jaswal SS, Kennedy C, Hayday A
and Carding SR: The generation of human γδ T cell repertoires
during fetal development. J Immunol. 160:5851–5860. 1998.PubMed/NCBI
|
|
9
|
Schlissel MS: Regulating antigen-receptor
gene assembly. Nat Rev Immunol. 3:890–899. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Rothenberg EV and Taghon T: Molecular
genetics of T cell development. Annu Rev Immunol. 23:601–649.
2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Surh CD and Sprent J: T cell apoptosis
detected in situ during positive and negative selection in the
thymus. Nature. 372:100–103. 1994.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Patel DR, Akhter A and Channabasappa N:
‘Bare lymphocyte syndrome: Clinical presentation and advances in
molecular diagnostics.’. Curr Allergy Asthma Rep. 20(21)2020.
|
|
13
|
Robey E, Chang D, Itano A, Cado D,
Alexander H, Lans D, Weinmaster G and Salmon P: An activated form
of Notch influences the choice between CD4 and CD8 T cell lineages.
Cell. 87:483–492. 1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yasutomo K: The cellular and molecular
mechanism of CD4/CD8 lineage commitment. J Med Invest. 49:1–6.
2002.PubMed/NCBI
|
|
15
|
Klein L, Kyewski B, Allen PM and Hogquist
KA: Positive and negative selection of the T cell repertoire: what
thymocytes see (and don't see). Nat Rev Immunol. 14:377–391.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Leung MW, Shen S and Lafaille JJ: ‘T cell
tolerance and autoimmunity: Emerging concepts.’. Ann Rev Immunol.
40:117–142. 2022.
|
|
17
|
Smith-Garvin JE, Koretzky GA and Jordan
MS: T cell activation. Annu Rev Immunol. 27:591–619.
2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kumar BV, Connors TJ and Farber DL: Human
T cell development, localization, and function throughout life.
Immunity. 48202-213:2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lanzavecchia A and Sallusto F: Dynamics of
T lymphocyte responses: Intermediates, effectors, and memory cells.
Science. 290:92–97. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Coyle AJ and Gutierrez-Ramos JC: The
expanding B7 superfamily: Increasing complexity in costimulatory
signals regulating T cell function. Nat Immunol. 2:203–209.
2001.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Croft M: Costimulation of T cells by OX40,
4-1BB, and CD27. Cytokine Growth Factor Rev. 14:265–273.
2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Guedan S, Posey AD Jr, Shaw C, Wing A, Da
T, Patel PR, McGettigan SE, Casado-Medrano V, Kawalekar OU,
Uribe-Herranz M, et al: Enhancing CAR T cell persistence through
ICOS and 4-1BB costimulation. JCI insight. 3(e96976)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Martinez-Llordella M, Esensten JH and
Turka LA: ‘Mechanisms of T cell anergy and implications for
immunotherapy.’. Nat Rev Immunol. 19:531–548. 2019.
|
|
24
|
Cui W and Kaech SM: Generation of effector
CD8+ T cells and their conversion into memory T cells. Immunity.
236:151–66. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Geginat J, Sallusto F and Lanzavecchia A:
Cytokine-driven proliferation and differentiation of human naive,
central memory and effector memory CD4+ T cells. Pathol Biol
(Paris). 51:64–66. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mescher MF, Curtsinger JM, Agarwal P,
Casey KA, Gerner M, Hammerbeck CD, Popescu F and Xiao Z: Signals
required for programming effector and memory development by CD8+ T
cells. Immunol Rev. 211:81–92. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Curtsinger JM, Lins DC and Mescher MF:
Signal 3 determines tolerance versus full activation of naive CD8 T
cells: Dissociating proliferation and development of effector
function. J Exp Med. 197:1141–1151. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kirberg J, Berns A and von Boehmer H:
Peripheral T cell survival requires continual ligation of the T
cell receptor to major histocompatibility complex-encoded
molecules. J Exp Med. 186:1269–1275. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Brocker T: Survival of mature CD4 T
lymphocytes is dependent on major histocompatibility complex class
II-expressing dendritic cells. J Exp Med. 186:1223–1232.
1997.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sckisel GD, Bouchlaka MN, Monjazeb AM,
Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E,
Mirsoian A, et al: Out-of-sequence signal 3 paralyzes primary CD4+
T cell-dependent immunity. Immunity. 43:240–250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tamiya T, Kashiwagi I, Takahashi R,
Yasukawa H and Yoshimura A: Suppressors of cytokine signaling
(SOCS) proteins and JAK/STAT pathways: Regulation of T cell
inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol.
31:980–985. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Takeda S, Rodewald HR, Arakawa H,
Bluethmann H and Shimizu T: MHC class II molecules are not required
for survival of newly generated CD4+ T cells, but affect their
long-term life span. Immunity. 5:217–228. 1996.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mackensen A, Müller L and Mougiakakos D:
CAR T cell therapy finds its way into autoimmunity. Nat Rev
Immunol. 22:71–72. 2022.
|
|
34
|
Schwab N, Schneider-Hohendorf T and Wiendl
H: Therapeutic uses of T cell modulation in autoimmunity and
beyond. J Clin Investig. 133(e164529)2023.
|
|
35
|
Irving BA and Weiss A: The cytoplasmic
domain of the T cell receptor zeta chain is sufficient to couple to
receptor-associated signal transduction pathways. Cell. 64:891–901.
1991.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kane LP, Lin J and Weiss A: Signal
transduction by the TCR for antigen. Curr Opin Immunol. 12:242–249.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lo WL, Shah NH, Ahsan N, Horkova V,
Stepanek O, Salomon AR, Kuriyan J and Weiss A: Lck promotes
Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT. Nat
Immunol. 19:733–741. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tan YX, Manz BN and Freedman TS:
‘Regulation of T cell receptor signaling by Lck and Fyn.’. Nat
Commun. 12(5032)2021.
|
|
39
|
Samelson LE, Patel MD, Weissman AM,
Harford JB and Klausner RD: Antigen activation of murine T cells
induces tyrosine phosphorylation of a polypeptide associated with
the T cell antigen receptor. Cell. 46:1083–1090. 1986.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Malissen B, Grégoire C, Malissen M and
Roncagalli R: Integrative biology of T cell activation. Nat
Immunol. 15:790–797. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Parsons SJ and Parsons JT: Src family
kinases, key regulators of signal transduction. Oncogene.
23:7906–7909. 2004.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Guy CS and Vignali DA: Organization of
proximal signal initiation at the TCR: CD3 complex. Immunol Rev.
232:7–21. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Finco TS, Kadlecek T, Zhang W, Samelson LE
and Weiss A: LAT is required for TCR-mediated activation of
PLCgamma1 and the Ras pathway. Immunity. 9:617–626. 1998.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang W, Sloan-Lancaster J, Kitchen J,
Trible RP and Samelson LE: LAT: The ZAP-70 tyrosine kinase
substrate that links T cell receptor to cellular activation. Cell.
92:83–92. 1998.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Dombroski D, Houghtling RA, Labno CM,
Precht P, Takesono A, Caplen NJ, Billadeau DD, Wange RL, Burkhardt
JK and Schwartzberg PL: Kinase-independent functions for Itk in
TCR-induced regulation of Vav and the actin cytoskeleton. J
Immunol. 174:1385–1392. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yokosuka T, Sakata-Sogawa K, Kobayashi W,
Hiroshima M, Hashimoto-Tane A, Tokunaga M, Dustin ML and Saito T:
Newly generated T cell receptor microclusters initiate and sustain
T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol.
6:1253–1262. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
47
|
Yablonski D, Kuhne MR, Kadlecek T and
Weiss A: Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1
in an SLP-76-deficient T cell. Science. 281:413–416.
1998.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Mak TW and Saunders ME: The immune
response. Part I: Basic Immunology 373-401, 2006.
|
|
49
|
Chandler NJ, Call MJ and Call ME: T cell
activation machinery: Form and function in natural and engineered
immune receptors. Int J Mol Sci. 21(7424)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Su X, Wang X, Wang Y, Zhang X, Qi J and
Ding Y: Phase separation of CD3ε-Lck condensates amplifies TCR
signaling but is dynamically terminated by Csk recruitment. Nat
Commun. 14(4723)2023.
|
|
51
|
Zeng C, Hou X, Yan X, Li M, Xu X and Jiang
S: Phospholipase Cγ1 promotes phase separation of LAT to regulate T
cell receptor signaling. Nat Commun. 12(3211)2021.
|
|
52
|
Sharpe AH and Freeman GJ: ‘The B7-CD28
superfamily: Emerging therapeutic targets.’. Nat Rev Immunol.
20:289–306. 2020.
|
|
53
|
Garçon F, Patton DT, Emery JL, Hirsch E,
Rottapel R, Sasaki T and Okkenhaug K: CD28 provides T cell
costimulation and enhances PI3K activity at the immune synapse
independently of its capacity to interact with the p85/p110
heterodimer. Blood. 111:1464–1471. 2008.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Boise LH, Minn AJ, Noel PJ, June CH,
Accavitti MA, Lindsten T and Thompson CB: CD28 costimulation can
promote T cell survival by enhancing the expression of Bcl-XL.
Immunity. 3:87–98. 1995.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kamphorst AO, Wieland A, Nasti T and Yang
S: ‘Immunoregulation by CD28 and its role in immune checkpoint
therapy.’. J Immunother Cancer. 8(e001021)2020.
|
|
56
|
Bjørgo E and Taskén K: Novel mechanism of
signaling by CD28. Immunol Lett. 129:1–6. 2010.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Green JM, Noel PJ, Sperling AI, Walunas
TL, Gray GS, Bluestone JA and Thompson CB: Absence of B7-dependent
responses in CD28-deficient mice. Immunity. 1:501–508.
1994.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ferguson SE, Han S, Kelsoe G and Thompson
CB: CD28 is required for germinal center formation. J Immunol.
156:4576–4581. 1996.PubMed/NCBI
|
|
59
|
Ogawa S, Nitta K, Hara Y, Horita S, Nihei
H and Abe R: CD28 knockout mice as a useful clue to examine the
pathogenesis of chronic graft-versus-host reaction. Kidney Int.
58:2215–2220. 2000.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Beyersdorf N, Ding X, Blank G, Dennehy KM,
Kerkau T and Hünig T: Protection from graft-versus-host disease
with a novel B7 binding site-specific mouse anti-mouse CD28
monoclonal antibody. Blood. 112:4328–4336. 2008.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Lucas JA, Miller AT, Atherly LO and Berg
LJ: The role of Tec family kinases in T cell development and
function. Immunol Rev. 191:119–138. 2003.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhong XP, Guo R, Zhou H, Liu C and Wan CK:
Diacylglycerol kinases in immune cell function and self-tolerance.
Immunol Rev. 224:249–264. 2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Gupta S: Mechanisms of transmembrane
signaling in human T cell activation. Mol Cell Biochem. 91:45–50.
1989.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Oh-hora M and Rao A: Calcium signaling in
lymphocytes. Curr Opin Immunol. 20:250–258. 2008.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Prakriya M, Feske S, Gwack Y, Srikanth S,
Rao A and Hogan PG: Orai1 is an essential pore subunit of the CRAC
channel. Nature. 443:230–233. 2006.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Nagaleekar VK, Diehl SA, Juncadella I,
Charland C, Muthusamy N, Eaton S, Haynes L, Garrett-Sinha LA,
Anguita J and Rincón M: IP3 receptor-mediated Ca2+ release in naive
CD4 T cells dictates their cytokine program. J Immunol.
181:8315–8322. 2008.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Liu J, Farmer JD Jr, Lane WS, Friedman J,
Weissman I and Schreiber SL: Calcineurin is a common target of
cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell.
66:807–815. 1991.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Macián F, López-Rodríguez C and Rao A:
Partners in transcription: NFAT and AP-1. Oncogene. 20:2476–2489.
2001.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Rooney JW, Sun YL, Glimcher LH and Hoey T:
Novel NFAT sites that mediate activation of the interleukin-2
promoter in response to T cell receptor stimulation. Mol Cell Biol.
15:6299–6310. 1995.PubMed/NCBI View Article : Google Scholar
|
|
70
|
López-Rodríguez C, Aramburu J, Rakeman AS
and Rao A: NFAT5, a constitutively nuclear NFAT protein that does
not cooperate with Fos and Jun. Proc Natl Acad Sci USA.
96:7214–7219. 1999.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Hogan PG, Lewis RS and Rao A: ‘Molecular
basis of calcium signaling in T cells.’. Nature Reviews Immunology.
19:532–548. 2019.
|
|
72
|
Feske S, Draeger R, Peter HH and Rao A:
Impaired NFAT regulation and its role in a severe combined
immunodeficiency. Immunobiology. 202:134–150. 2000.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ebinu JO, Stang SL, Teixeira C, Bottorff
DA, Hooton J, Blumberg PM, Barry M, Bleakley RC, Ostergaard HL and
Stone JC: RasGRP links T cell receptor signaling to Ras. Blood.
95:3199–3203. 2000.PubMed/NCBI
|
|
74
|
Zhong XP, Hainey EA, Olenchock BA, Zhao H,
Topham MK and Koretzky GA: Regulation of T cell receptor-induced
activation of the Ras-ERK pathway by diacylglycerol kinase zata. J
Biol Chem. 277:31089–31098. 2002.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Shin J, O'Brien TF, Grayson JM and Zhong
XP: Differential regulation of primary and memory CD8 T cell immune
responses by diacylglycerol kinases. J Immunol. 188:2111–2117.
2012.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Chen Y, Ci X, Gorentla B, Sullivan SA,
Stone JC, Zhang W, Pereira P, Lu J and Zhong XP: Differential
requirement of RasGRP1 for γδ T cell development and activation. J
Immunol. 189:61–71. 2012.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Mor A, Philips MR and Pillinger MH: The
role of Ras signaling in lupus T lymphocytes: Biology and
pathogenesis. Clin Immunol. 125:215–223. 2007.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Szamel M and Resch K: T-cell antigen
receptor-induced signal-transduction pathways: Activation and
function of protein kinases C in T lymphocytes. Eur J Biochem.
228:1–15. 1995.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hayden MS and Ghosh S: . NF-kappaB in
immunobiology. Cell Res. 21:223–244. 2011.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Dower NA, Stang SL, Bottorff DA, Ebinu JO,
Dickie P, Ostergaard HL and Stone JC: RasGRP is essential for mouse
thymocyte differentiation and TCR signaling. Nat Immunol.
1:317–321. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
81
|
Krappmann D, Emmerich F, Kordes U,
Scharschmidt E, Dörken B and Scheidereit C: Molecular mechanisms of
constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg
cells. Oncogene. 18:943–953. 1999.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Staudt LM: Oncogenic activation of
NF-kappaB. Cold Spring Harb Perspect Biol.
2(a000109)2010.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Merida I, Andrada E, Gharbi SI and
Avila-Flores A: ‘DAG signaling in T cells: From membrane biophysics
to immune function.’. Front Immunol. 11(3122)2020.
|
